Nadine Norton, PhD

  • 14640 Citations
  • 54 Scopus h-Index
19972018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nadine Norton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Schizophrenia Medicine & Life Sciences
Genes Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Bipolar Disorder Medicine & Life Sciences
Genome-Wide Association Study Medicine & Life Sciences
Genome Medicine & Life Sciences
Dilated Cardiomyopathy Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1997 2018

8 Citations (Scopus)

Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes

Knowles, D. A., Burrows, C. K., Blischak, J. D., Patterson, K. M., Serie, D. J., Norton, N., Ober, C., Pritchard, J. K. & Gilad, Y., May 8 2018, In : eLife. 7, e33480.

Research output: Contribution to journalArticle

Quantitative Trait Loci
Anthracyclines
Cardiac Myocytes
Doxorubicin
Genes
1 Citation (Scopus)

Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer

Norton, N., Fox, N., McCarl, C. A., Tenner, K. S., Ballman, K., Erskine, C. L., Necela, B. M., Northfelt, D. W., Tan, W., Calfa, C., Pegram, M., Colon-Otero, G., Perez, E. A., Clynes, R. & Knutson, K. L., Jun 14 2018, In : Breast Cancer Research. 20, 1, 52.

Research output: Contribution to journalArticle

Immunity
Breast Neoplasms
Recurrence
Antibodies
Disease-Free Survival
8 Citations (Scopus)

Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial

Serie, D. J., Crook, J., Necela, B. M., Dockter, T. J., Wang, X., Asmann, Y., Fairweather, D., Bruno, K. A., Colon-Otero, G., Perez, E. A., Thompson, E. A. & Norton, N., 2017, In : Pharmacogenetics and Genomics. 27, 10, p. 378-385 8 p.

Research output: Contribution to journalArticle

Genome-Wide Association Study
Single Nucleotide Polymorphism
Stroke Volume
Paclitaxel
Anthracyclines
12 Citations (Scopus)

Intrinsic subtype and therapeutic response among HER2-positive breast tumors from the NCCTG (Alliance) N9831 trial

Perez, E. A., Ballman, K. V., Mashadi-Hossein, A., Tenner, K. S., Kachergus, J. M., Norton, N., Necela, B. M., Carr, J. M., Ferree, S., Perou, C. M., Baehner, F., Cheang, M. C. U. & Thompson, E. A., 2017, In : Journal of the National Cancer Institute. 109, 2

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasms
Therapeutics
Confidence Intervals
Recurrence

The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes

Necela, B. M., Axenfeld, B. C., Serie, D. J., Kachergus, J. M., Perez, E. A., Thompson, E. A. & Norton, N., Jan 18 2017, In : Clinical and Translational Medicine. 6, 1, 5.

Research output: Contribution to journalArticle

Cardiac Myocytes
Antineoplastic Agents
Gene Expression
Glucose
Gene Ontology